Project ID: D2016-29 IP Status: PCT patent application filed Invention Description and Novelty: “Thin” molecules offer stronger binding to PPAR and include greater lipid burning and glucose lowering properties. Applications: Dyslipidemia, obesity and type II diabetes Value propositions: • B.....
[Detail]
Faster shutter speedHigher frame rateHigher sensitivityNo mechanical scanning
[Detail]
Shih-Fu Chang, Ph.D.
[Detail]
Membrane proteins (MP) mediate many of the cell’s fundamental processes and MPs are embedded in the cell’s membrane lipid bilayer. Currently, MPs are targets for about 60% of therapeutic drugs in use. However, MPs are very difficult to manipulate and study because they require both an aqueous enviro.....
[Detail]
Platelet accumulation at sites of vascular injury, even if unintentionally introduced during surgical procedures, is a life-threatening event, for which there are currently no highly-specific treatments. Current drugs dampen platelets or block their ability to form a thrombus, but since they block p.....
[Detail]
| |< <- | [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] | -> >| |
